查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420394

全球水产养殖饲料和药品市场-全球产业分析,规模,份额,成长,趋势,预测 (2031) - 按产品类型、按类别、按地区

Aquaculture Feed and Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 202 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球水产养殖饲料和药品市场规模将达9.994亿美元。全球对这些产品的需求稳定，预计复合年增长率 (CAGR) 为 7.4%。因此，到 2031 年底，市场规模预计将达到 20 亿美元。

由于药品和生物製品领域的不断进步和研究，全球水产养殖饲料和药品市场预计到 2031 年将显着成长。最近的市场分析显示，药品和生物製剂领域在价值和成长方面已成为该行业的主导力量，生物製剂细分领域在预测期内的复合年增长率达到惊人的7.7%，创历史新高，预计将压倒整个行业。其他的。

在各种产品类型中，药品和生物製剂领域是最赚钱的领域，市场吸引力指数为1.6。相较之下，药物饲料领域的吸引力预计最低，市场吸引力指数为 0.4。

该报告考察了全球水产养殖饲料和药品市场，并提供了市场概况，包括按产品类型、物种、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第三章 2018-2031年全球水产养殖饲料及药品市场展望

  • 2018-2031 年全球水产养殖饲料和药品市场展望，按产品类型和价值（十亿美元）划分
  • 2018-2031 年全球水产养殖饲料和药品市场展望、类型和价值（十亿美元）
  • 全球水产养殖饲料和药品市场展望，按地区，价值（十亿美元），2018-2031

第四章 2018-2031年北美水产养殖饲料及药品市场展望

第五章 2018-2031年欧洲水产养殖饲料及药品市场展望

第六章 2018-2031 年亚太水产养殖饲料及药品市场展望

第七章 2018-2031 年拉丁美洲水产养殖饲料与药品市场展望

第八章 2018-2031年中东和非洲水产养殖饲料和药品市场展望

第9章 竞争格局

  • 按产品类型和类型划分的热图
  • 2023 年公司市场份额分析
  • 比赛仪表板
  • 公司简介
    • Zoetis, Inc.
    • Schouw & Co
    • Ridley Corporation Ltd
    • Merck & Co Inc
    • Biomin Holding GmbH
    • Aller Aqua A/S
    • Nutriad Ltd.
    • Alltech Inc.
    • Avanti Feeds Ltd.
    • Norel S.A.
    • Cargill, Incorporated
    • Beneo GmbH
    • Skretting AS

第10章附录

简介目录

The global market size for aquaculture feed and pharmaceuticals is currently estimated to be at US$ 999.4 million in 2024. It is anticipated that there will be a steady demand for these products worldwide, with a projected Compound Annual Growth Rate (CAGR) of 7.4%. As a result, the market is expected to reach a valuation of US$ 2 billion by the conclusion of 2031.

The global aquaculture feed and pharmaceuticals market is poised for significant growth through 2031, driven by continuous advancements and research in the field of pharmaceuticals and biologics. A recent market analysis indicates that the pharmaceutical and biologics segment will emerge as the dominant force in this industry, both in terms of value and growth with the biologics sub-segment expected to outperform others, boasting an impressive 7.7% compound annual growth rate (CAGR) during the forecast period.

Most Lucrative Segment with Strong Market Attractiveness

Among various product types, the pharmaceutical and biologics segment is set to be the most lucrative, boasting a market attractiveness index of 1.6. In contrast, the medicated feed segment is expected to be the least attractive, with a market attractiveness index of 0.4.

Driving Factors Behind Market Growth

Several factors are fueling the growth of the pharmaceutical and biologics segment in the aquaculture feed and pharmaceuticals market. There is a growing demand for structured research and development in the aquaculture field, particularly in biologics research. This has led to a faster introduction of drugs, medicated feed, and vaccines into regional markets, particularly in developed countries such as the United States and Canada. Such initiatives have stimulated inorganic growth through strategic partnerships and M&A activities among key industry players.

Key Trends and Developments

In the United States, the use of extra label drugs in aquaculture, under the guidance of licensed veterinarians, has opened up opportunities for the development of medicated feed and pharmaceuticals. Regulatory bodies, such as the FDA, support the use of approved extra label aquaculture medicated feeds, provided they meet compliance conditions. This development is expected to expand the scope for further advancements in medicated feed and pharmaceuticals for aquaculture.

Furthermore, the demand for in-feed medication as a prophylactic measure is on the rise in the global aquaculture feed and pharmaceutical market. The adoption of in-feed medication to prevent the spread of diseases among healthy fish is growing, particularly in organized fishing farms across Europe. This trend aligns with the limited use of antibiotics in the region.

Governmental Collaborations Drive R&D

Governments in various countries are initiating collaborative research and development efforts in partnership with regulatory bodies to enhance the availability of high-quality medicated feed and pharmaceuticals for aquaculture. As aquaculture becomes a crucial source of food for human consumption, the need for safe and effective treatments for various fish diseases has grown significantly.

Challenges Ahead

Despite the growth prospects, the lack of harmonization of veterinary medicinal products and medicated feed regulations across different regions, particularly in the European Union, poses challenges. Different laws for manufacturing veterinary medicines and medicated feed, along with varying residue limits of veterinary medicines in feed, hinder market estimation and forecasting efforts.

Competitive Analysis:

Some of the prominent players in the global market for aquaculture feed & pharmaceutical market are:

  • Zoetis, Inc.
  • Schouw & Co
  • Ridley Corporation Ltd
  • Merck & Co Inc
  • Biomin Holding GmbH
  • Aller Aqua A/S
  • Nutriad Ltd.
  • Alltech Inc.
  • Avanti Feeds Ltd.
  • Norel S.A.
  • Cargill, Incorporated
  • Beneo GmbH
  • Skretting AS
  • Novus International Inc.
  • Growel Feeds Pvt. Ltd.
  • Neovia Vietnam
  • Evonik Industries AG
  • Bayer AG
  • Koninklijke DSM N.V
  • Others.

Market Segmentation

Product Type

  • Pharmaceutical and Biologics

Anti-infectives

Parasiticides

Biologics

Others

  • Medicated Feed

Vitamins and Minerals

Amino Acids

Acidifiers

Others

Species

  • Molluscs
  • Shrimp
  • Salmons
  • Carps
  • Tilapia
  • Catfish
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Aquaculture Feed and Pharmaceutical Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 3.1. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pharmaceutical and Biologics
        • 3.1.1.1.1. Anti-infectives
        • 3.1.1.1.2. Parasiticides
        • 3.1.1.1.3. Biologics
        • 3.1.1.1.4. Others
      • 3.1.1.2. Medicated Feed
        • 3.1.1.2.1. Vitamins and Minerals
        • 3.1.1.2.2. Amino Acids
        • 3.1.1.2.3. Acidifiers
        • 3.1.1.2.4. Others
  • 3.2. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Molluscs
      • 3.2.1.2. Shrimp
      • 3.2.1.3. Salmons
      • 3.2.1.4. Carps
      • 3.2.1.5. Tilapia
      • 3.2.1.6. Catfish
      • 3.2.1.7. Others
  • 3.3. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 4.1. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Pharmaceutical and Biologics
        • 4.1.1.1.1. Anti-infectives
        • 4.1.1.1.2. Parasiticides
        • 4.1.1.1.3. Biologics
        • 4.1.1.1.4. Others
      • 4.1.1.2. Medicated Feed
        • 4.1.1.2.1. Vitamins and Minerals
        • 4.1.1.2.2. Amino Acids
        • 4.1.1.2.3. Acidifiers
        • 4.1.1.2.4. Others
  • 4.2. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Molluscs
      • 4.2.1.2. Shrimp
      • 4.2.1.3. Salmons
      • 4.2.1.4. Carps
      • 4.2.1.5. Tilapia
      • 4.2.1.6. Catfish
      • 4.2.1.7. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 5.1. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Pharmaceutical and Biologics
        • 5.1.1.1.1. Anti-infectives
        • 5.1.1.1.2. Parasiticides
        • 5.1.1.1.3. Biologics
        • 5.1.1.1.4. Others
      • 5.1.1.2. Medicated Feed
        • 5.1.1.2.1. Vitamins and Minerals
        • 5.1.1.2.2. Amino Acids
        • 5.1.1.2.3. Acidifiers
        • 5.1.1.2.4. Others
  • 5.2. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Molluscs
      • 5.2.1.2. Shrimp
      • 5.2.1.3. Salmons
      • 5.2.1.4. Carps
      • 5.2.1.5. Tilapia
      • 5.2.1.6. Catfish
      • 5.2.1.7. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Pharmaceutical and Biologics
        • 6.1.1.1.1. Anti-infectives
        • 6.1.1.1.2. Parasiticides
        • 6.1.1.1.3. Biologics
        • 6.1.1.1.4. Others
      • 6.1.1.2. Medicated Feed
        • 6.1.1.2.1. Vitamins and Minerals
        • 6.1.1.2.2. Amino Acids
        • 6.1.1.2.3. Acidifiers
        • 6.1.1.2.4. Others
  • 6.2. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Molluscs
      • 6.2.1.2. Shrimp
      • 6.2.1.3. Salmons
      • 6.2.1.4. Carps
      • 6.2.1.5. Tilapia
      • 6.2.1.6. Catfish
      • 6.2.1.7. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 7.1. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Pharmaceutical and Biologics
        • 7.1.1.1.1. Anti-infectives
        • 7.1.1.1.2. Parasiticides
        • 7.1.1.1.3. Biologics
        • 7.1.1.1.4. Others
      • 7.1.1.2. Medicated Feed
        • 7.1.1.2.1. Vitamins and Minerals
        • 7.1.1.2.2. Amino Acids
        • 7.1.1.2.3. Acidifiers
        • 7.1.1.2.4. Others
  • 7.2. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Molluscs
      • 7.2.1.2. Shrimp
      • 7.2.1.3. Salmons
      • 7.2.1.4. Carps
      • 7.2.1.5. Tilapia
      • 7.2.1.6. Catfish
      • 7.2.1.7. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Pharmaceutical and Biologics
        • 8.1.1.1.1. Anti-infectives
        • 8.1.1.1.2. Parasiticides
        • 8.1.1.1.3. Biologics
        • 8.1.1.1.4. Others
      • 8.1.1.2. Medicated Feed
        • 8.1.1.2.1. Vitamins and Minerals
        • 8.1.1.2.2. Amino Acids
        • 8.1.1.2.3. Acidifiers
        • 8.1.1.2.4. Others
  • 8.2. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Molluscs
      • 8.2.1.2. Shrimp
      • 8.2.1.3. Salmons
      • 8.2.1.4. Carps
      • 8.2.1.5. Tilapia
      • 8.2.1.6. Catfish
      • 8.2.1.7. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Species Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Zoetis, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Schouw & Co
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Ridley Corporation Ltd
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Merck & Co Inc
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Biomin Holding GmbH
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Aller Aqua A/S
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Nutriad Ltd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alltech Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Avanti Feeds Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Norel S.A.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Cargill, Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Beneo GmbH
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Skretting AS
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations